What is “FABNO”

Dr. Edwards is a Fellow of the American Board of Naturopathic Oncology - FABNO


stethoscope-doctor-medical-blood-pressure-161489.jpeg

The American Board of Naturopathic Oncology – the board certification branch of the OncANP – provides the most rigorous additional education and certification available for Naturopathic Doctors (NDs) interested in cancer care in North America and worldwide. Designation as a Fellow of the American Board of Naturopathic Oncology (FABNO) requires meeting a strict set of criteria including:

  • 2-year CNME-accredited residency focused on naturopathic oncology, as determined by the ABNO Board of Medical Examiners  OR in practice for at least 5 years with 2250 oncology patient contacts  AND

  • Submit cases for review by designated examiners AND

  • 50 CEs in oncology-related topics

All approved applicants must then pass a board certification exam.

Re-certification is required every 10 years.

The ABNO Core Curriculum emphasizes the following:

  • The evaluation and management of patients with malignancies with an understanding of established standards and a multidisciplinary approach.

  • Clinical experience that is focused on integrative patient management, coordinating care with medical, radiation and surgical oncology, as well as palliative care and other integrative disciplines.

  • Develop expertise to evolve one’s clinical practice in the context of a rapidly developing area of specialization and complex patient management.

  • Develop the ability to evaluate and conduct research.

Applicants found to meet these criteria are then eligible to sit for the Board Certification examination. Certification as a Fellow of the American Board of Naturopathic Oncology (FABNO) was recognized by the AANP in 2006.

The State of Arizona recognizes the Naturopathic Oncology Specialty. Dr. Edwards holds Oncology Specialty Certificate #26-019SP.

Naturopathic physicians with a FABNO designation are committed to excellence in integrative oncology and to furthering the science and knowledge for the benefit of patients.

For more information visit www.oncanp.org